THE PROTECTIVE EFFECT OF MOCLOBEMIDE AGAINST HYPOXIA-INDUCED LETHALITY IN MICE IS NOT DUE TO A DECREASE IN BODY-TEMPERATURE
dc.authorid | Ulugol, Ahmet/0000-0003-4643-1124 | |
dc.authorid | Karadag, Cetin Hakan/0000-0002-4763-986X | |
dc.authorwosid | Ulugol, Ahmet/V-9665-2019 | |
dc.authorwosid | Karadag, Cetin Hakan/H-4899-2013 | |
dc.contributor.author | ULUGOL, A | |
dc.contributor.author | KARADAG, HC | |
dc.contributor.author | DOKMECI, D | |
dc.contributor.author | ALKHATIB, I | |
dc.contributor.author | DOKMECI, I | |
dc.date.accessioned | 2024-06-12T11:08:40Z | |
dc.date.available | 2024-06-12T11:08:40Z | |
dc.date.issued | 1995 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | The protective effect of moclobemide, a reversible and highly selective inhibitor of monoamine oxidase-A, against hypoxia-induced lethality was investigated in the present experiment. Moclobemide showed an apparent protective potency against hypoxia and significantly prolonged the latencies for convulsions and death in a dose-dependent manner. Hypothermia is known to protect animals from hypoxia. Moclobemide also decreased body temperature in mice; however, the hypothermic effect was unrelated to the antihypoxic effect. These results suggest that the protective effect of moclobemide in hypoxia is not due to a decrease in body temperature. | en_US |
dc.identifier.doi | 10.1016/0091-3057(94)00366-Q | |
dc.identifier.endpage | 247 | en_US |
dc.identifier.issn | 0091-3057 | |
dc.identifier.issue | 2-3 | en_US |
dc.identifier.pmid | 7667335 | en_US |
dc.identifier.scopus | 2-s2.0-0029042334 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 245 | en_US |
dc.identifier.uri | https://doi.org/10.1016/0091-3057(94)00366-Q | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/22510 | |
dc.identifier.volume | 51 | en_US |
dc.identifier.wos | WOS:A1995RB49100012 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Pergamon-Elsevier Science Ltd | en_US |
dc.relation.ispartof | Pharmacology Biochemistry And Behavior | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | MOCLOBEMIDE | en_US |
dc.subject | HYPOXIA | en_US |
dc.subject | BODY TEMPERATURE | en_US |
dc.subject | Oxidase Type-A | en_US |
dc.subject | Barbiturate Protection | en_US |
dc.subject | Reversible Inhibitor | en_US |
dc.subject | Hypothermia | en_US |
dc.subject | Pharmacology | en_US |
dc.subject | Profile | en_US |
dc.subject | Drugs | en_US |
dc.title | THE PROTECTIVE EFFECT OF MOCLOBEMIDE AGAINST HYPOXIA-INDUCED LETHALITY IN MICE IS NOT DUE TO A DECREASE IN BODY-TEMPERATURE | en_US |
dc.type | Article | en_US |